Blueprint Genetics
Blueprint Genetics is a genetic testing company headquartered in Helsinki, Finland that was founded in 2012 by Juha Koskenvuo, Samuel Myllykangas, Tero-Pekka Alastalo, and Tommi Lehtonenis. The company offers genetic testing, genetic diagnostics, and clinical interpretation of genomic data for medical professionals.
All edits
On September 1, 2014 Blueprint Genetics closed a venture funding round with $3.9 million in funding from Inventure.
On December 31, 2016 Blueprint Genetics closed their second venture funding round with €6 million in funding from Pontos Group and Inventure.
On July 11, 2017 Blueprint Genomics closed their series A funding round with €14 million in funding from MTIP AG, Creathor Ventures, Inventure, Pontos Group, and Stanford University.
Blueprint Genetics
Blueprint Genetics is a genetic testing company headquartered in Helsinki, Finland that was founded in 2012 by Juha Koskenvuo, Samuel Myllykangas, Tero-Pekka Alastalo, and Tommi Lehtonenis. The company offers genetic testing, genetic diagnostics, and clinical interpretation of genomic data for medical professionals.
Blueprint Genetics is a genetic testing company headquartered in Helsinki, Finland that was founded in 2012 by Juha Koskenvuo, Samuel Myllykangas, Tero-Pekka Alastalo, and Tommi Lehtonenis. The company offers genetic testing, genetic diagnostics, and clinical interpretation of genomic data for medical professionals.
Find more companies like Blueprint Genetics
